Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.38 Million - $1.66 Million
10,000 Added 20.0%
60,000 $9.7 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $1.34 Million - $1.54 Million
-10,000 Reduced 16.67%
50,000 $6.71 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $3.3 Million - $4.09 Million
-25,000 Reduced 29.41%
60,000 $9.73 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $1.07 Million - $1.36 Million
-10,000 Reduced 10.53%
85,000 $11.5 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $2.13 Million - $2.42 Million
20,000 Added 26.67%
95,000 $10.2 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $526,050 - $586,050
-5,000 Reduced 6.25%
75,000 $8.45 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $1.05 Million - $1.15 Million
-10,250 Reduced 11.36%
80,000 $8.66 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $825,022 - $1.11 Million
10,250 Added 12.81%
90,250 $9.67 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $429,550 - $504,150
5,000 Added 6.67%
80,000 $7.01 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $2.93 Million - $3.93 Million
-40,000 Reduced 34.78%
75,000 $7.36 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $7.42 Million - $11.2 Million
115,000 New
115,000 $8.76 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cna Financial Corp Portfolio

Follow Cna Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cna Financial Corp with notifications on news.